Entos Pharmaceuticals and the L-CMD Research Foundation Collaborate to Develop Curative Therapy for LMNA-Related Congenital Muscular Dystrophy

EDMONTON, Alberta & SAN DIEGO–(BUSINESS WIRE)– #LCMD–Entos and L-CMD Foundation partner to develop potentially curative gene therapy for L-CMD, a rare, fatal, childhood disease.
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks